CD4 and Patent ductus arteriosus: Mirlekar and Pylayeva-Gupta [25] found that IL35 is an important immunosuppressive driver in pancreatic ductal adenocarcinoma (PDA) and potentiates tumor growth via the suppression of endogenous antitumor CD4+ effector T cell responses.